| Inositol 1,3,4,5-Tetrakisphosphate | Not Available |
| Ribose-5-phosphate | Not Available |
| Platelet Activating Factor | Not Available |
| 1-Deoxy-D-xylulose 5-phosphate | 1-Deoxy-D-xylulose 5-phosphate is a solid. This compound belongs to the pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. The proteins that 1-Deoxy-D-xylulose... |
| D-glucitol 6-phosphate | Not Available |
| Glucosamine 6-Phosphate | Not Available |
| Glucosamine 4-Phosphate | Not Available |
| Inositol 1,3-Bisphosphate | Not Available |
| Glucosamine 1-Phosphate | Not Available |
| Lysophosphatidylglycerol | Not Available |
| Glucose-6-Phosphate | An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is... |
| Indole-3-Glycerol Phosphate | Not Available |
| Phosphatidylethanolamine | Not Available |
| Fructose-6-phosphate | Not Available |
| Choline alfoscerate | A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids. (From Stedman, 26th ed) It counteracts the effects of urea on enzymes... |
| Lucinactant | Intended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. |
| ETC-588 | Investigated for use/treatment in atherosclerosis, coronary artery disease, and vascular diseases. |
| Colfosceril palmitate | A pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature infants. |
| Sodium glycerophosphate | A medication used to treat hypophosphatemia. |
| DL-dimyristoylphosphatidylcholine | DL-dimyristoylphosphatidylcholine is not an active pharmaceutical agent and has no indication. |
| DL-dimyristoylphosphatidylglycerol | DL-dimyristoylphosphatidylglycerol is not an considered an active pharmacological ingredient in pharmaceutical preparations and so has no official indications. |
| Mifamurtide | A muramyl dipeptide derivative used to treat high grade, resectable, non-metastatic osteosarcoma after surgical resection. |
| Fosfructose | Not Annotated |
| 1,2-Distearoyllecithin | Not Annotated |
| 5-O-phosphono-alpha-D-ribofuranosyl diphosphate | The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides. |
| L-xylitol 5-phosphate | Not Available |
| alpha-D-glucose-1-phosphate | Not Available |
| 1D-myo-inositol 1,4,5-trisphosphate | Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the... |
| Inositol 2,4,5-trisphosphate | Not Available |
| Dihydroxyacetone phosphate | Dihydroxyacetone phosphate is an important intermediate in lipid biosynthesis and in glycolysis. Dihydroxyacetone phosphate has been investigated for the treatment of Lymphoma, Large-Cell, Diffuse. |
| VB-201 | VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis). |
| Phosphatidyl serine | A nutrient used in some supplement products. |
| 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | Not Available |
| Glycerol 2-phosphate | Not Available |
| L-Dilinoleoyllecithin | Not Available |
| sn-glycero-3-phosphoethanolamine | Not Available |
| Cadaverine | Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine. |
| 1D-myo-inositol 1,3,4-trisphosphate | Not Available |
| Phytic acid | Phytic acid is under investigation in clinical trial NCT01000233 (Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications). |
| Lecithin | A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols. |